The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling ...
Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...
High drug prices and low drug reimbursements have made it increasingly difficult to keep a pharmacy running — much less ...
Mark Cuban warned Cost Plus Drugs could raise prices due to potential tariffs. The pharmacy can't absorb the impact of a high ...
Lobbyist Danny Thompson, representing the Pharmaceutical Industry Labor and Management Association (PILMA), said PBMs in ...